| Line Item | 2024-06-29 | Y/Y |
|---|---|---|
| Revenue | $1.36B | -23.1% |
| Gross Profit | $251.5M | -55.8% |
| R&D Expense | $302.2M | -1.8% |
| SG&A Expense | $310.7M | -10.9% |
| Operating Income | -$434.0M | -275.1% |
| Income Tax | $140.8M | +382.2% |
| Net Income | -$546.5M | -315.3% |
| EPS (Basic) | -$8.12 | -320.7% |
| EPS (Diluted) | -$8.12 |
| Line Item | 2024-06-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $436.7M | -49.2% |
| Short-term Investments | $450.3M | -61.0% |
| Inventory | $398.4M | -2.5% |
| Current Assets | $1.59B | -42.8% |
| Total Assets | $3.93B | -15.1% |
| Current Liabilities | $269.3M | -57.5% |
| Total Liabilities | $2.97B | -9.2% |
| Line Item | 2024-06-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.7M | -86.3% |
| Capital Expenditures | $133.0M | +3.5% |
| Investing Cash Flow | -$114.3M | +86.9% |
| Financing Cash Flow | -$332.7M | -226.5% |
| Free Cash Flow | -$108.3M | -311.1% |
| -320.7% |
| Stockholders' Equity |
| $957.3M |
| -29.4% |